Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

121.08 +1.27 (+1.06%)
Streaming Delayed Price Updated: 3:19 PM EDT, Sep 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
TransMedics Group Inc (NASDAQ:TMDX) Emerges as a Top Affordable Growth Stock
TransMedics (TMDX) is a top affordable growth stock with strong revenue & EPS growth, solid financial health, and a reasonable valuation in the organ transplant tech sector. 
Via Chartmill
The Analyst Verdict: TransMedics Group In The Eyes Of 4 Experts
 
Via Benzinga
If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today
 
Via Benzinga
$100 Invested In TransMedics Group 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
TransMedEDICS Group Inc (NASDAQ:TMDX): An Affordable Growth Candidate in Organ Transplant Technology
TransMedics (TMDX) shows explosive revenue & EPS growth, trading at a reasonable valuation given its strong position in the organ transplant tech market. 
Via Chartmill
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts
 
Via Benzinga
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Price Over Earnings Overview: TransMedics Group
 
Via Benzinga
Price Over Earnings Overview: TransMedics Group
 
Via Benzinga
Spotlight on TransMedics Group: Analyzing the Surge in Options Activity
 
Via Benzinga
RadNet Posts Better-Than-Expected Earnings, Joins Tegna, MeridianLink, Lithium Argentina And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
TransMedics Group Inc (NASDAQ:TMDX): A Prime Example of Affordable Growth Investing
Affordable Growth investing balances strong revenue/earnings growth with fair pricing, as seen in TransMedics (TMDX), with high growth metrics, reasonable valuation, and stable finances. 
Via Chartmill
What TransMedics Just Taught Me About Trusting The Algorithm
 
Via Benzinga
4 Analysts Have This To Say About TransMedics Group
 
Via Benzinga
Why TransMedics Stock Is Skyrocketing Today
TransMedics continues to lock in its status as the leader in organ transplant technology. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
TransMedics (TMDX) Q2 Revenue Jumps 38%
Via The Motley Fool
TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook
TransMedics Group shares are rising in Wednesday's after-hours session after the company reported financial results for the second quarter. 
Via Benzinga
Topics Earnings
TransMedics Sees Its Earnings Soar
TransMedics reported second-quarter financial results that were considerably better than most investors had anticipated. Investors were also pleased that TransMedics increased its guidance for the full... 
Via The Motley Fool
Top 3 Health Care Stocks That Could Blast Off In July
 
Via Benzinga
Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge
 
Via Benzinga
TRANSMEDICS GROUP INC (NASDAQ:TMDX) – A High-Growth Momentum Stock with Strong Technical Setup
TRANSMEDICS (TMDX) shows strong earnings momentum with 500% EPS growth and a solid technical setup, making it a candidate for high-growth investors. 
Via Chartmill
Is TransMedics Stock a Buy After Short-Seller Drama?
Via The Motley Fool
2 Stocks That Have Doubled This Year and Are Still Worth Buying
Via The Motley Fool
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
Via The Motley Fool
Topics Artificial Intelligence
Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May
TransMedics Group and two other mid-cap names just posted dominant performances in Q1, smashing forecasts set by Wall Street analysts. 
Via MarketBeat
Topics Earnings
3 Medical Technology Stocks Outperforming in 2025
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns. 
Via MarketBeat
3 High-Growth Stocks Traders Love and Investors Should Watch
These three small stocks carry significant risk, but that volatility has served traders well this year; now it's time for long-term investors to take a look 
Via MarketBeat
Topics Economy
TRANSMEDICS GROUP INC (NASDAQ:TMDX) – A High-Growth Momentum Stock with Strong Technical Setup
TRANSMEDICS (TMDX) shows strong earnings growth and improving margins while presenting a favorable technical setup, making it interesting for momentum investors. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.